Boston Athenæum

May 21, 2018 at the Boston Athenæum. Join us for a panel discussion that will explore exciting developments in the life sciences. The latest trends in gene therapy, gene editing, and RNA interference--to name a few subjects--will be examined. The panelists will also trace the journey of consumer and clinical products from the spark of an idea to product-testing in the lab. Other questions for discussion include: What are current trends in the life sciences and how can they be extended into the future? And what impact will those trends have on the greater Boston area? Come learn about this fascinating field and its impact on both an individual and societal level. Carl Zimmer, esteemed science writer for the New York Times, will serve as moderator for the panel comprised of three outstanding speakers: Nobel Laureate Dr. Craig C. Mello representing academic research, Dr. Adam Koppel of Bain Capital Life Science Ventures representing venture capital, and Dr. David Meeker of KSQ Therapeutics, formerly of Genzyme